tiprankstipranks
CytomX Therapeutics Inc. (CTMX)
NASDAQ:CTMX
CTMX
CytomX Therapeutics
RESEARCH TOOLSreports

CytomX Therapeutics (CTMX) Revenue

947 Followers
StatisticsMarket CapRevenue

CytomX Therapeutics Revenue

CytomX Therapeutics had a revenue of 663.00K in the quarter ending Dec 31, 2025, with -88.88%. This bring the company's revenue in the last twelve months to 76.20M, Increased -32.94%. In the fiscal year ending Dec 31, 2025, CytomX Therapeutics had annual revenue of 76.20M with -44.82% growth.
Revenue (ttm)
76.20M
Revenue Growth
-10.26%
P/S Ratio
12.94
Revenue/Employee
$640,345
Employees
119
Market Cap
$985.77M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
76.20M-61.90M-44.82%
Dec 31, 2024
138.10M36.89M+36.45%
Dec 31, 2023
101.21M48.05M+90.38%
Dec 31, 2022
53.16M15.85M+42.48%
Dec 31, 2021
37.31M-31.11M-45.47%
Dec 31, 2020
68.43M10.94M+19.03%
Dec 31, 2019
57.49M-2.01M-3.38%
Dec 31, 2018
59.50M-12.12M-16.92%
Dec 31, 2017
71.62M――